Depletion of mitotic Olig2+ progenitors or Olig2 ablation impeded tumor initiation, indicating that glial lineage-associated OLIG2+ progenitors are cellular origin of SHH MBs and OLIG2-driven oncogenic networks as potential therapeutic targets. The gene discussed is OLIG2; the disease is neoplasm.